Patents by Inventor Samuel J. Balin

Samuel J. Balin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods related to polycytotoxic T cells
    Patent number: 11096965
    Abstract: Various aspects of the invention relate to compositions comprising polycytotoxic T cells. Some aspects relate to methods for obtaining a composition comprising polycytotoxic T cells. Some aspects relate to methods of administering a composition comprising polycytotoxic T cells to a subject. Some aspects relate to methods for monitoring an immune response in a subject, comprising determining the concentration of polycytotoxic T cells in the blood of the subject. Some aspects relate to methods for treating a condition or disease in a subject, comprising administering to the subject a composition comprising an antibody, or an antigen-binding portion thereof, that specifically binds to a protein expressed by a polycytotoxic T cell.
    Type: Grant
    Filed: April 4, 2017
    Date of Patent: August 24, 2021
    Assignees: The Regents of the University of California, ULM UNIVERSITY
    Inventors: Samuel J. Balin, Robert L. Modlin, Steffen Stenger, Matteo Pellegrini
  • COMPOSITIONS AND METHODS RELATED TO POLYCYTOTOXIC T CELLS
    Publication number: 20190117689
    Abstract: Various aspects of the invention relate to compositions comprising polycytotoxic T cells. Some aspects relate to methods for obtaining a composition comprising polycytotoxic T cells. Some aspects relate to methods of administering a composition comprising polycytotoxic T cells to a subject. Some aspects relate to methods for monitoring an immune response in a subject, comprising determining the concentration of polycytotoxic T cells in the blood of the subject. Some aspects relate to methods for treating a condition or disease in a subject, comprising administering to the subject a composition comprising an antibody, or an antigen-binding portion thereof, that specifically binds to a protein expressed by a polycytotoxic T cell.
    Type: Application
    Filed: April 4, 2017
    Publication date: April 25, 2019
    Inventors: Samuel J. Balin, Robert L. Modlin, Steffen Stenger, Matteo Pellegrini